Paper Details

  1. Home
  2. Paper Details

Comparison of aerosolized glycopyrrolate and metaproterenol in acute asthma.

Author: CarterJ, GilmanM J, MeyerL, SlovisC

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Nebulized glycopyrrolate, an anticholinergic drug, was found to be as effective as metaproterenol, a beta-agonist, in treating acute asthma. Glycopyrrolate did not cause the tremors, palpitations, and paresthesias associated with metaproterenol, and its effect on heart rate was significantly less than that of metaproterenol.
Paper Details　
Original Abstract of the Article :
The efficacy of nebulized glycopyrrolate compared with metaproterenol was evaluated in 46 patients with acute asthma. In a double-blinded, randomized fashion, patients received, as sole therapy, either 2 mg of glycopyrrolate or 15 mg of metaproterenol every 2 h over a 6-h study period. Of the 35 pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1378/chest.98.5.1095

データ提供：米国国立医学図書館（NLM）

A Breath of Relief: Glycopyrrolate vs. Metaproterenol for Asthma

Acute asthma attacks can be like a sandstorm, making it difficult to breathe. This study investigated two medications, glycopyrrolate and metaproterenol, to see how they compare in treating acute asthma. The researchers conducted a double-blind, randomized study, meaning neither the patients nor the researchers knew which medication was being given. They found that both medications were equally effective at opening up the airways, but glycopyrrolate had fewer side effects, particularly tremors, palpitations, and tingling sensations.

Glycopyrrolate: A Smoother Ride Through the Sandstorm

Glycopyrrolate, with its gentler side effect profile, may be a more comfortable option for some asthma patients, particularly those who are concerned about tremors, palpitations, and tingling sensations.

Navigating the Asthma Desert

This study underscores the importance of finding the right medication for each individual with asthma. Just as a desert traveler needs to choose the right camel for their journey, asthma patients need to work with their doctors to find the best treatment for their specific needs. This study provides valuable information to help guide these decisions.

Dr. Camel's Conclusion

This research, like a cool breeze in the desert, sheds light on the effectiveness of glycopyrrolate in treating acute asthma. While both medications were effective, glycopyrrolate offered a smoother ride through the sandstorm of symptoms. This study underscores the importance of finding a treatment that suits each individual’s unique needs, making the journey through the desert of asthma a little less bumpy.

Date :
  1. Date Completed 1990-12-05
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

2225951

DOI: Digital Object Identifier

10.1378/chest.98.5.1095

Related Literature

Article Analysis
・Side Effects of metaproterenol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.